Utilization of risk assessment tools in management of PAH: A PAH provider survey-Reference-Cited by-同舟云学术

Utilization of risk assessment tools in management of PAH: A PAH provider survey

Published:2022-04 Issue:2 Volume:12 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Sahay Sandeep¹^ORCID,Balasubramanian Vijay²,Memon Humna³,Poms Abby⁴,Bossone Eduardo⁵^ORCID,Highland Kristine⁶,Kay Dana⁷,Levine Deborah J⁸,Mullin Christopher J⁹,Melendres‐Groves Lana¹⁰,Mathai Stephen C¹¹,Soto Francisco J¹²,Shlobin Oksana¹³,Elwing Jean M⁷^ORCID

Affiliation:

1. Division of Pulmonary Critical Care & Sleep Medicine Houston Methodist Hospital Houston Texas USA

2. Division of Pulmonary & Critical Care Medicine UCSF Fresno Fresno California USA

3. Spectrum Health Grand Rapids Michigan USA

4. Poms Research Consultants Chapel Hill North Carolina USA

5. Division of Cardiology A. Cardarelli Hospital Naples Italy

6. Respiratory Institute Cleveland Clinic Ohio USA

7. Division of Pulmonary & Critical Care Medicine University of Cincinnati College of Medicine Cincinnnati Ohio

8. Division of Pulmonary & Critical Care Medicine University of Texas Health Science Center at San Antonio San Antonio Texas USA

9. Division of Pulmonary & Critical Care Medicine Warren Alpert Medical School of Brown University Providence Rhode Island USA

10. Division of Pulmonary & Critical Care Medicine University of New Mexico Health Science Center Albuquerque New Mexico USA

11. Division of Pulmonary & Critical Care Medicine John Hopkins University Baltimore Maryland USA

12. Division of Pulmonary & Critical Care Medicine University of Tennessee Medical Center Knoxville Tennessee USA

13. Pulmonary Hypertension Program, Inova Fairfax Hospital Fairfax Virginia USA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pul2.12057

Reference18 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2. Update in treatment options in pulmonary hypertension

3. An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

4. Assessing risk in pulmonary arterial hypertension: what we know, what we don't

5. The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective;American Journal of Respiratory and Critical Care Medicine;2024-09-01

2. Risk stratification and treatment goals in pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

3. End-of-Life and Palliative Care Issues for Patients Living with Pulmonary Arterial Hypertension: Barriers and Opportunities;Seminars in Respiratory and Critical Care Medicine;2023-07-17

4. Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives;Journal of Clinical Medicine;2023-06-28

5. Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines;Pulmonary Circulation;2023-04